Safety Study of AZD5672 in Renally Impaired Subjects
NCT00715702
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Renal Impairment
Interventions
DRUG:
AZD5672
Sponsor
AstraZeneca